Similar articles

• Pharmacological facilitation of coronary intervention in ST-segment elevation myocardial infarction: time is of the essence.

  Gersh BJ, Stone GW. Gersh BJ, et al. JACC Cardiovasc Interv. 2010 Dec;3(12):1292-4. doi: 10.1016/j.jcin.2010.08.024. JACC Cardiovasc Interv. 2010. PMID: 21232724 No abstract available.
• ST segment resolution in ASSENT 3: insights into the role of three different treatment strategies for acute myocardial infarction.

  Armstrong PW, Wagner G, Goodman SG, Van de Werf F, Granger C, Wallentin L, Fu Y; ASSENT 3 Investigators. Armstrong PW, et al. Eur Heart J. 2003 Aug;24(16):1515-22. doi: 10.1016/s0195-668x(03)00322-1. Eur Heart J. 2003. PMID: 12919776 Clinical Trial.
• A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study.

  Armstrong PW; WEST Steering Committee. Armstrong PW, et al. Eur Heart J. 2006 Jul;27(13):1530-8. doi: 10.1093/eurheartj/ehl088. Epub 2006 Jun 6. Eur Heart J. 2006. PMID: 16757491 Clinical Trial.
• Management of ST-segment elevation myocardial infarction in EDs.

  Diercks DB, Kontos MC, Weber JE, Amsterdam EA. Diercks DB, et al. Am J Emerg Med. 2008 Jan;26(1):91-100. doi: 10.1016/j.ajem.2007.06.014. Am J Emerg Med. 2008. PMID: 18082788 Review.
• Failed thrombolysis in myocardial infarction.

  Qasim A, Chauhan A, More RS. Qasim A, et al. Int J Cardiol. 2000 Aug;75(1):5-14. doi: 10.1016/s0167-5273(00)00282-5. Int J Cardiol. 2000. PMID: 11054500 Review.